Bullish
IQVIA Holdings Inc. offers an "Orchestrated Patient Recruitment" program that leverages real-world data, analytics, and multi-channel outreach to acce...
This article provides financial actuals and estimates for IQVIA Holdings Inc. (NYSE:IQV), including its current stock price, historical performance, a...
Bearish
Morgan Stanley has downgraded IQVIA Holdings Inc (IQV) to Equal-Weight from Overweight, lowering its price target from $225.00 to $200.00 due to a cau...
Neutral
Wiley and IQVIA released a cross-sector report, "Scientific Discovery & AI: The Science-to-Patient Journey," based on insights from over 25 senior lea...
Bullish
Wiley and IQVIA have released a cross-sector report titled "Scientific Discovery & AI: The Science-to-Patient Journey," which summarizes insights from...
Neutral
IQVIA Holdings Inc., through its subsidiary IQVIA Inc., issued €950 million in 4.625% Senior Notes due 2034. These notes, detailed in an 8-K filing, a...
Neutral
IQVIA Holdings Inc. (IQV) is a large-cap company providing healthcare research services, with a market cap of $30.7 billion. While IQV stock has under...
Bullish
TD Cowen has raised its price target for IQVIA Holdings Inc. (IQV) from $213 to $233, while reiterating a "Buy" rating on the stock. This adjustment r...
Neutral
IQVIA Holdings Inc. announced that its subsidiary, IQVIA Inc., priced an offering of €950 million in senior notes due 2033 with an interest rate of 4....
Neutral
IQVIA Holdings Inc. announced that its subsidiary, IQVIA Inc., priced an offering of €950,000,000 in senior notes due 2033 with an interest rate of 4....
IQVIA Holdings Inc. announced that its subsidiary, IQVIA Inc., priced an offering of €950 million in senior notes due 2033. These notes will bear inte...